ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,118.90
0.42%
Dow Jones
43,408.47
0.32%
Gold vs US Dollar
2,672.175
0.74%
Brent Oil
73.90
1.46%
Bitcoin
98,030.15
3.89%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Hutchmed (china) Limited (HCM)

  7. Hutchmed (china) Limited (HCM) News

Hutchmed (china) (HCM)

Hutchmed (china) Limited
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:HCM
DateTimeSourceHeadlineSymbolCompany
20/11/202409:30RNS Regulatory NewsHutchmed (China) Limited Appointment of Independent Non-executive DirectorLSE:HCMHutchmed (china) Limited
06/11/202407:00RNS Non-RegulatoryHutchmed (China) Limited Clinical Data to be Presented at ASH and ESMO AsiaLSE:HCMHutchmed (china) Limited
31/10/202412:02Alliance NewsAlliance NewsHutchmed China receives first milestone payment for Takeda drug salesLSE:HCMHutchmed (china) Limited
31/10/202408:30RNS Non-RegulatoryHutchmed (China) Limited First Commercial Milestone PaymentLSE:HCMHutchmed (china) Limited
31/10/202408:30RNS Regulatory NewsHutchmed (China) Limited Total Voting RightsLSE:HCMHutchmed (china) Limited
21/10/202408:30RNS Regulatory NewsHutchmed (China) Limited Vesting of awards under the LTIPLSE:HCMHutchmed (china) Limited
16/10/202408:52Alliance NewsAlliance NewsTOP NEWS: AstraZeneca's Tagrisso plus Orpathys shows promising resultsLSE:HCMHutchmed (china) Limited
16/10/202406:00RNS Regulatory NewsHutchmed (China) Limited SAVANNAH: clinically meaningful response rateLSE:HCMHutchmed (china) Limited
24/09/202407:49Alliance NewsAlliance NewsTakeda Pharmaceutical says Fruzaqla cancer drug gets Japan backingLSE:HCMHutchmed (china) Limited
24/09/202407:00RNS Regulatory NewsHutchmed (China) Limited Japan Approval for FRUZAQLALSE:HCMHutchmed (china) Limited
09/09/202406:00RNS Non-RegulatoryHutchmed (China) Limited Clinical Data to be Presented at ESMO and WCLCLSE:HCMHutchmed (china) Limited
30/08/202411:24Alliance NewsAlliance NewsHutchmed "disappointed" as it withdraws fruquintinib applicationLSE:HCMHutchmed (china) Limited
30/08/202408:30RNS Regulatory NewsHutchmed (China) Limited Total Voting RightsLSE:HCMHutchmed (china) Limited
30/08/202406:00RNS Regulatory NewsHutchmed (China) Limited Update on Fruquintinib for Gastric Cancer in ChinaLSE:HCMHutchmed (china) Limited
22/08/202408:30RNS Regulatory NewsHutchmed (China) Limited Standard form for notification of major holdingsLSE:HCMHutchmed (china) Limited
21/08/202408:30RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED to Host Expert Call to discuss ITPLSE:HCMHutchmed (china) Limited
06/08/202409:00RNS Regulatory NewsHutchmed (China) Limited LTIP and Share Option SchemeLSE:HCMHutchmed (china) Limited
31/07/202413:41Alliance NewsAlliance NewsHutchmed confident of full year guidance for oncology and immunologyLSE:HCMHutchmed (china) Limited
31/07/202411:00RNS Regulatory NewsHutchmed (China) Limited 2024 Interim Results and Business UpdatesLSE:HCMHutchmed (china) Limited
05/07/202418:08Alliance NewsAlliance NewsIN BRIEF: Hutchmed's tazemetostat given priority review in ChinaLSE:HCMHutchmed (china) Limited
04/07/202406:00RNS Non-RegulatoryHutchmed (China) Limited NDA Acceptance in China for TazemetostatLSE:HCMHutchmed (china) Limited
28/06/202411:35RNS Non-RegulatoryHutchmed (China) Limited Overseas Regulatory Announcement: Form F-3 FilingLSE:HCMHutchmed (china) Limited
28/06/202408:30RNS Regulatory NewsHutchmed (China) Limited Blocklisting Six Monthly ReturnLSE:HCMHutchmed (china) Limited
28/06/202408:30RNS Regulatory NewsHutchmed (China) Limited Total Voting RightsLSE:HCMHutchmed (china) Limited
26/06/202408:30RNS Regulatory NewsHutchmed (China) Limited HUTCHMED to Announce 2024 HY Financial ResultsLSE:HCMHutchmed (china) Limited
24/06/202409:30RNS Non-RegulatoryHutchmed (China) Limited Save the Date: HUTCHMED to Present R&D UpdatesLSE:HCMHutchmed (china) Limited
24/06/202409:00Alliance NewsAlliance NewsIN BRIEF: Hutchmed China notes Takeda obtains EU approval for FruzaqlaLSE:HCMHutchmed (china) Limited
24/06/202406:00RNS Regulatory NewsHutchmed (China) Limited European Commission Approval for FRUZAQLALSE:HCMHutchmed (china) Limited
17/06/202409:32Alliance NewsAlliance NewsHutchmed celebrates "promising" results for sovleplenib in ChinaLSE:HCMHutchmed (china) Limited
17/06/202406:00RNS Non-RegulatoryHutchmed (China) Limited Lancet Publish Phase III ESLIM-01 ResultsLSE:HCMHutchmed (china) Limited
 Showing the most relevant articles for your search:LSE:HCM

Your Recent History

LSE
VAST
Vast Resources
LSE
POS
Plexus
LSE
SYME
Supply@me Capital
LSE
MIN
Minoan
LSE
LIO
Liontrust Asset Management
LSE
STX
Shield Therapeutics
LSE
GGP
Greatland Gold
LSE
POLX
Polarean Imaging
LSE
TERN
Tern
LSE
LLOY
Lloyds Banking
LSE
MTRO
Metro Bank
LSE
NEXN
Nexxen
LSE
ITM
Itm Power
LSE
JD.
Jd Sports Fashion
LSE
AAZ
Anglo Asian Mining
LSE
GFM
Griffin Mining
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 40%, 2 years 50% and *3 years 60%
    EU Flag

    *Across 3 years £2132.64 only £853.06